Upgrade to SI Premium - Free Trial

Assembly Biosciences (ASMB) PT Lowered to $45 at Mizuho

August 31, 2026 2:00 PM
Mizuho analyst Salim Syed lowered the price target on Assembly Biosciences (NASDAQ: ASMB) to $45.00 (from $53.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change